Health Care
More on Health Care
Sanders, Cummings, Booker, Casey, Doggett, Heinrich, King to Unveil Drug Importation Bill to Help Lower Prescription Drug Costs for Middle Class Families
Members of Congress Have Reached Agreement on Language to Allow Importation While Maintaining Drug Safety
Cummings Issues Statement in Response to President Trump's Press Conference
Washington, D.C. (Feb. 16, 2017)—Today, Rep. Elijah E. Cummings, Ranking Member of the House Committee on Oversight and Government Reform, issued the following statement in response to President Donald Trump's press conference:
"I have no idea why President Trump would make up a story about me like he did today. Of course, Senator Schumer never told me to skip a meeting with the President.
WASHINGTON, Feb. 13 – Sen. Bernie Sanders (I-Vt.) and Rep. Elijah Cummings (D-Md.), ranking member of the House Committee on Oversight and Government Reform, sent a letter to Marathon Pharmaceuticals Monday demanding answers about its plan to charge $89,000 per year for deflazacort, a drug that is widely available abroad for approximately $1,000 per year.
Oversight and Energy & Commerce Dems Release State Fact Sheets on Impact of GOP Assault on ACA
3.4 Million Kids at Risk of Losing Coverage if Republicans Repeal Law
Washington, D.C. (Dec. 16, 2016)—Today, Rep. Elijah E.
Cummings Issues Response to Republican Plan to Repeal ACA
Washington, D.C. (Dec. 7, 2016)—Today, Rep. Elijah E. Cummings, Ranking Member of the House Committee on Oversight and Government Reform, issued the following statement in response to reports that Republicans plan to partially repeal the Affordable Care Act through the budget reconciliation process:
Following Efforts by Casey, Wyden, and Cummings, GAO Releases Results of CMS Nursing Home Rating SystemWashington, D.C. - Following a push by U.S. Senator Bob Casey (D-PA) and Senate Finance Committee Ranking Member Ron Wyden (D-OR), and Representative Elijah E. |